Global Patent Index - EP 3242671 A4

EP 3242671 A4 20180808 - EX VIVO METHODS FOR MINIMIZING RISKS AND MAXIMIZING BENEFITS OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION

Title (en)

EX VIVO METHODS FOR MINIMIZING RISKS AND MAXIMIZING BENEFITS OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION

Title (de)

EX VIVO-VERFAHREN ZUR MINIMIERUNG DER RISIKEN UND MAXIMIERUNG DER VORTEILE VON ALLOGENER BLUT- UND KNOCHENMARKTRANSPLANTATION

Title (fr)

PROCÉDÉS EX VIVO POUR MINIMISER LES RISQUES ET MAXIMISER LES EFFETS BÉNÉFIQUES D'UNE TRANSFUSION DE SANG ALLOGÉNIQUE ET GREFFE DE MOELLE

Publication

EP 3242671 A4 20180808 (EN)

Application

EP 16735447 A 20160108

Priority

  • US 201562101181 P 20150108
  • US 2016012573 W 20160108

Abstract (en)

[origin: WO2016112245A1] The described invention provides an ex vivo model of persistent T lymphocyte stimulation events encountered by circulating T lymphocytes at lymph node and tissue levels in vivo; a method for optimizing donor selection for allogeneic blood and marrow transplantation (BMT) therapy; and a method for minimizing risks and maximizing benefits of performing allogeneic blood and marrow transplantation (BMT) therapy in a recipient subject, wherein the recipient subject has a hematologic malignancy.

IPC 8 full level

A61K 35/17 (2015.01)

CPC (source: EP)

A61K 39/4611 (2023.05); A61K 39/4615 (2023.05); A61K 39/4621 (2023.05); A61K 39/4622 (2023.05); A61K 39/46434 (2023.05); G01N 33/505 (2013.01); A61K 2239/26 (2023.05); G01N 2800/245 (2013.01)

Citation (search report)

  • [A] US 2011027804 A1 20110203 - YARMUSH MARTIN L [US], et al
  • [A] US 2014038279 A1 20140206 - INGBER DONALD E [US], et al
  • [A] US 2004259177 A1 20041223 - LOWERY ROBERT G [US], et al
  • [A] WO 2008060449 A2 20080522 - HARVARD COLLEGE [US], et al
  • [A] US 5827642 A 19981027 - RIDDELL STANLEY R [US], et al
  • [A] DMITRY SAMSONOV ET AL: "Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro", TRANSPLANTATION RESEARCH, BIOMED CENTRAL LTD, LONDON, UK, vol. 1, no. 1, 24 April 2012 (2012-04-24), pages 4, XP021124468, ISSN: 2047-1440, DOI: 10.1186/2047-1440-1-4
  • [A] STYBAYEVA G ET AL: "Micropatterned co-cultures of T-lymphocytes and epithelial cells as a model of mucosal immune system", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 380, no. 3, 13 March 2009 (2009-03-13), pages 575 - 580, XP026422257, ISSN: 0006-291X, [retrieved on 20090131], DOI: 10.1016/J.BBRC.2009.01.164
  • [A] VÉRONIQUE LECAULT ET AL: "Microfluidic cell culture arrays for clonal expansion and characterization of mammalian cells", 1 January 2012 (2012-01-01), XP055487736, Retrieved from the Internet <URL:http://dataaccess-p.internal.epo.org/dal/data/documents/nonpatent>
  • [A] CARLENS STEFAN ET AL: "Ex vivo T lymphocyte expansion for retroviral transduction: Influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution", EXPERIMENTAL HEMATO, ELSEVIER INC, US, vol. 28, no. 10, 1 October 2000 (2000-10-01), pages 1137 - 1146, XP009165868, ISSN: 0301-472X, DOI: 10.1016/S0301-472X(00)00526-9
  • See also references of WO 2016112245A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2016112245 A1 20160714; CA 2972846 A1 20160714; EP 3242671 A1 20171115; EP 3242671 A4 20180808

DOCDB simple family (application)

US 2016012573 W 20160108; CA 2972846 A 20160108; EP 16735447 A 20160108